Examining the Clinical Effectiveness of Non-Carbapenem β-Lactams for the Treatment of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae.

about

Examining the Clinical Effectiveness of Non-Carbapenem β-Lactams for the Treatment of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae.

Item

http://www.wikidata.org/entity/Q38792841

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Examining the Clinical Effecti ...... -Producing Enterobacteriaceae.

@en

type

Item

label

Examining the Clinical Effecti ...... -Producing Enterobacteriaceae.

@en

prefLabel

Examining the Clinical Effecti ...... -Producing Enterobacteriaceae.

@en

P1476

Examining the Clinical Effecti ...... e-Producing Enterobacteriaceae

@en

P2093

Allison M Gibble

http://www.w3.org/2001/XMLSchema#string

Angela M Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Extended-spectrum beta-lactamases: a clinical update

Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome.

Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to the expression of extended-spectrum beta-lactamases

Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory.

Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination.

Ceftolozane/tazobactam: a novel cephalosporin/β-lactamase inhibitor combination with activity against multidrug-resistant gram-negative bacilli.

Endocarditis caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: emergence of resistance to ciprofloxacin and piperacillin-tazobactam during treatment despite initial susceptibility.

The inoculum effect of antibiotics against CTX-M-extended-spectrum β-lactamase-producing Escherichia coli.

Susceptibility of extended-spectrum-beta-lactamase-producing Enterobacteriaceae according to the new CLSI breakpoints.

Comparable outcomes for β-lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaxime-resistant Escherichia coli or Klebsiella pneumoniae.

P304

653-666

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/ANTIBIOTICS4040653

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alan E Gross

P577

2015-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

287149351

http://www.w3.org/2001/XMLSchema#string

P698

27025645

http://www.w3.org/2001/XMLSchema#string

P921

carbapenem antibiotic

P932

4790318

http://www.w3.org/2001/XMLSchema#string